米RNA通过调节免疫系统的反应来影响乳腺癌的进展
Yeqin Fu1, Qiuhui Yang2, Ning Xu3
1Zhejiang cancer hospital, Hangzhou, Zhejiang 310022, China; Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang 310022, China.
概括
微RNAs (miRNAs) 在乳腺癌 (BC) 的进展和免疫反应中起着至关重要的作用. 了解瘤免疫微环境 (TME) 中的miRNA功能为BC免疫疗法提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 乳腺癌 (BC) 是妇女死亡的主要原因,目前的治疗包括手术,化疗和放射治疗.
- 结核病的发展越来越多地与炎症性免疫反应有关,突出显示了免疫治疗的潜力.
- 微RNAs (miRNAs) 在BC诊断,预后和进展中发挥着重要作用,影响瘤与免疫相互作用.
研究的目的:
- 审查miRNAs和免疫成分在乳腺癌 (BC) 进展中的功能.
- 评估使用miRNAs在BC免疫治疗中的潜力.
- 探索异常miRNA表达如何影响瘤免疫微环境 (TME).
主要方法:
- 关于乳腺癌 (BC) 中miRNA功能研究的文献综述.
- 分析miRNA在调节免疫细胞和瘤免疫微环境 (TME) 内的因素中的作用.
- 评估miRNAs用于BC免疫疗法的治疗潜力.
主要成果:
- 异常的miRNA表达可以通过影响瘤细胞和免疫反应来促进或抑制BC进展.
- 微RNAs是TME中瘤细胞和免疫细胞之间通信的关键媒介.
- 失调的miRNAs可以抑制免疫细胞的生成和激活,促进瘤的增殖.
结论:
- miRNAs是乳腺癌 (BC) 免疫微环境的重要调节者.
- 针对miRNAs提供了一个有前途的策略,用于开发BC.的新型免疫疗法.
- 对miRNA介导的免疫调节的进一步研究可以推进BC治疗.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461


